arBtrage CAPITALIZING MARKETS checking… Sign in

Corbus Pharmaceuticals Holdings, Inc.

CRBP Health Care Biotechnology: Pharmaceutical Preparations
$7.56
▼ -5.6% Today
as of Jun 7, 07:12 ET
Last 30 days -23.01% Apr 28 → Jun 05
$7.00 $8.38 $9.76 $11.15 $12.53 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$7.91
High
$7.92
Low
$7.56
Volume
$326,825
Avg Vol
$297,995
Mkt Cap
$142M
P/E (TTM)
Beta
52w High
$20.56
52w Low
$6.72
Div Yield
Shares Out
$18M

Overview

52-week range
$6.72
$21
6% of range
Avg surprise (last 2)
-4.0%
Avg reaction (last 2)
-6.1%
50% positive
Latest IV / EM
119%
EM ±16.5% · $8 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-2.27$-1.91$-1.55$-1.19$-0.83 Actual $-2.05Actual $-2.27Actual $-0.83Actual $-0.90Actual $-1.15Actual $-1.39Est $-1.26Actual $-1.44Actual $-1.90Actual $-1.23Est $-1.26 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-23M$-20M$-17M$-14M$-10M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 12, 2026Mar/2026 $-1.23 $-1.26 +2.4% +11.5% +3.5% earnings
Tue Sep 30, 2025Sep 2025 $-1.90 financials
Mon Jun 30, 2025Jun 2025 $-1.44 financials
Tue May 6, 2025Mar/2025 $-1.39 $-1.26 -10.3% -15.8% earnings
Mon Sep 30, 2024Sep 2024 $-1.15 financials
Sun Jun 30, 2024Jun 2024 $-0.90 financials
Sun Mar 31, 2024Mar 2024 $-0.83 financials
Sat Sep 30, 2023Sep 2023 $-2.27 financials
Fri Jun 30, 2023Jun 2023 $-2.05 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-24M$-24M$-19M$-20M$-16M$-11M
Net income$-23M$-23M$-18M$-17M$-14M$-10M
EPS (diluted)$-1.23$-1.90$-1.44$-1.39$-1.15$-0.90

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$26M$28M$27M$20M$19M$17M$19M$24M
Inventory
Total current assets$144M$167M$108M$123M$137M$153M$161M$148M
Total assets$144M$168M$110M$125M$140M$156M$164M$152M
Long-term debt
Total liabilities$18M$21M$17M$14M$13M$13M$14M$26M
Total equity$126M$148M$92M$111M$127M$142M$150M$126M

Implied volatility — last 90 days

114%116%119%121%124% Jun 07 — IV 119% · EM ±16.5%

Sector peers